About Rama SmartSearch
RamaOnHealthcare brings signal to noise to keep you up-to-date with the latest healthcare industry news. We continuously refine our search algorithm to help you quickly and easily find the most relevant and human-vetted content from the best sources and authors.
Smart Topics: Rama SmartSearch identifies popular industry keywords as "Smart Topics" and searches article titles for related industry keywords.
You may simply combine keywords to narrow search results. Alternatively, you may use the "AND" operator to also combine keywords.
You may use the "OR" operator to broaden search results to match one or more keywords. Alternatively, you may use the "|" operator to also broaden search results.
You may use quotes to find exact matches, where the keywords are matched in order.
You may use the dash operator to exclude keywords and quoted exact matches from search results.
STAT August 8, 2024
Eli Lilly raised its full-year revenue guidance by $3 billion, driven by massive sales of its GLP-1-based diabetes and obesity drugs Mounjaro and Zepbound.
The pharma giant on Thursday boosted its forecast for 2024 sales to a range of $45.4 billion to $46.6 billion, up from the previously guided range of $42.4 to $43.6 billion. It also raised its guidance for adjusted earnings per share to a range of $16.10 to $16.60...
